Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Blackaby
Barry Graham Blackaby, West Simsbury, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080264730 | Elevator System Control Providing Specialized Service Features - An elevator system ( | 10-30-2008 |
| 20110088984 | ELEVATOR SYSTEM CONTROL PROVIDING SPECIALIZED SERVICE FEATURES - An elevator system ( | 04-21-2011 |
Wesley Blackaby, Saffron Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20110212102 | HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 09-01-2011 |
| 20110217311 | CYCLOALKYL CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-08-2011 |
Wesley Blackaby, Saffron Walden Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20110212103 | THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-01-2011 |
Wesley Blackaby, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20120071460 | PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS - The present invention relates to pyrazole oxadiazoles derivatives of Formula (I), and their use for treating multiple sclerosis and other diseases, wherein R | 03-22-2012 |
Wesley Peter Blackaby, Buckhurst Hill GB
| Patent application number | Description | Published |
|---|---|---|
| 20100029726 | CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA - The present invention provides compounds of formula I: | 02-04-2010 |
Wesley Peter Blackaby, Epping GB
| Patent application number | Description | Published |
|---|---|---|
| 20090286765 | Therapeutic Agents - A compound of the formula (I): wherein R | 11-19-2009 |
| 20100222317 | Azetidine Derivatives as GlyT1 Inhibitors - The present invention relates to compounds of formula (I); and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof, as GIyT1 inhibitors for treating neurological and psychiatric disorders. | 09-02-2010 |
Wesley Peter Blackaby, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20110098325 | PYRIDINE BENZAMIDES AND PYRAZINE BENZAMIDES USED AS PKD INHIBITORS - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain pyridine benzamide and pyrazine benzamide compounds (referred to herein as PDBA and PZBA compounds) which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc. | 04-28-2011 |